These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36719128)

  • 21. GNAO1 encephalopathy: further delineation of a severe neurodevelopmental syndrome affecting females.
    Marcé-Grau A; Dalton J; López-Pisón J; García-Jiménez MC; Monge-Galindo L; Cuenca-León E; Giraldo J; Macaya A
    Orphanet J Rare Dis; 2016 Apr; 11():38. PubMed ID: 27072799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epileptic encephalopathy, movement disorder, and the yin and yang of
    Pearson TS; Helbig I
    Neurology; 2017 Aug; 89(8):754-755. PubMed ID: 28747451
    [No Abstract]   [Full Text] [Related]  

  • 23. Dystonia as a prominent presenting feature in developmental and epileptic encephalopathies: A case series.
    Dzinovic I; Škorvánek M; Necpál J; Boesch S; Švantnerová J; Wagner M; Havránková P; Pavelekova P; Haň V; Janzarik WG; Berweck S; Diebold I; Kuster A; Jech R; Winkelmann J; Zech M
    Parkinsonism Relat Disord; 2021 Sep; 90():73-78. PubMed ID: 34399161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive Movement Disorder in Brothers Carrying a GNAO1 Mutation Responsive to Deep Brain Stimulation.
    Kulkarni N; Tang S; Bhardwaj R; Bernes S; Grebe TA
    J Child Neurol; 2016 Feb; 31(2):211-4. PubMed ID: 26060304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A patient with a GNAO1 mutation with decreased spontaneous movements, hypotonia, and dystonic features.
    Okumura A; Maruyama K; Shibata M; Kurahashi H; Ishii A; Numoto S; Hirose S; Kawai T; Iso M; Kataoka S; Okuno Y; Muramatsu H; Kojima S
    Brain Dev; 2018 Nov; 40(10):926-930. PubMed ID: 29935962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A mechanistic review on GNAO1-associated movement disorder.
    Feng H; Khalil S; Neubig RR; Sidiropoulos C
    Neurobiol Dis; 2018 Aug; 116():131-141. PubMed ID: 29758257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GNAO1 Mutations Affecting the N-Terminal α-Helix of Gαo Lead to Parkinsonism.
    Solis GP; Larasati YA; Thiel M; Koval A; Koy A; Katanaev VL
    Mov Disord; 2024 Mar; 39(3):601-606. PubMed ID: 38358016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes.
    Feng H; Larrivee CL; Demireva EY; Xie H; Leipprandt JR; Neubig RR
    PLoS One; 2019; 14(1):e0211066. PubMed ID: 30682176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical whole-exome sequencing reveals a novel missense pathogenic variant of GNAO1 in a patient with infantile-onset epilepsy.
    Law CY; Chang ST; Cho SY; Yau EK; Ng GS; Fong NC; Lam CW
    Clin Chim Acta; 2015 Dec; 451(Pt B):292-6. PubMed ID: 26485252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visual Function in Children with GNAO1-Related Encephalopathy.
    Gambardella ML; Pede E; Orazi L; Leone S; Quintiliani M; Amorelli GM; Petrianni M; Galanti M; Amore F; Musto E; Perulli M; Contaldo I; Veredice C; Mercuri EM; Battaglia DI; Ricci D
    Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic modeling of GNAO1 disorder delineates mechanisms of Gαo dysfunction.
    Wang D; Dao M; Muntean BS; Giles AC; Martemyanov KA; Grill B
    Hum Mol Genet; 2022 Feb; 31(4):510-522. PubMed ID: 34508586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Dynamic Simulations to Determine Individualized Therapy: Tetrabenazine for the GNAO1 Encephalopathy E246K Variant.
    Falsaperla R; Sortino V; Marino SD; Collotta AD; Gammeri C; Sipala FM; Volti GL; Ruggieri M; Ronsisvalle S
    Mol Diagn Ther; 2024 May; 28(3):329-337. PubMed ID: 38581611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype-phenotype correlation and treatment effects in young patients with
    Thiel M; Bamborschke D; Janzarik WG; Assmann B; Zittel S; Patzer S; Auhuber A; Opp J; Matzker E; Bevot A; Seeger J; van Baalen A; Stüve B; Brockmann K; Cirak S; Koy A
    J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):806-815. PubMed ID: 37225406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular and phenotypic spectrum of IQSEC2-related epilepsy.
    Zerem A; Haginoya K; Lev D; Blumkin L; Kivity S; Linder I; Shoubridge C; Palmer EE; Field M; Boyle J; Chitayat D; Gaillard WD; Kossoff EH; Willems M; Geneviève D; Tran-Mau-Them F; Epstein O; Heyman E; Dugan S; Masurel-Paulet A; Piton A; Kleefstra T; Pfundt R; Sato R; Tzschach A; Matsumoto N; Saitsu H; Leshinsky-Silver E; Lerman-Sagie T
    Epilepsia; 2016 Nov; 57(11):1858-1869. PubMed ID: 27665735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding Phenotype of De Novo Mutations in GNAO1: Four New Cases and Review of Literature.
    Schorling DC; Dietel T; Evers C; Hinderhofer K; Korinthenberg R; Ezzo D; Bönnemann CG; Kirschner J
    Neuropediatrics; 2017 Oct; 48(5):371-377. PubMed ID: 28628939
    [No Abstract]   [Full Text] [Related]  

  • 36. Dystonic Cerebral Palsy Phenotype Due to GNAO1 Variant Responsive to Levodopa.
    Vasconcellos LF; Soares VP; de Ricchezza LL
    Tremor Other Hyperkinet Mov (N Y); 2023; 13():11. PubMed ID: 37034444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Course of Six Children With GNAO1 Mutations Causing a Severe and Distinctive Movement Disorder.
    Ananth AL; Robichaux-Viehoever A; Kim YM; Hanson-Kahn A; Cox R; Enns GM; Strober J; Willing M; Schlaggar BL; Wu YW; Bernstein JA
    Pediatr Neurol; 2016 Jun; 59():81-4. PubMed ID: 27068059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GNAO1-related neurodevelopmental disorder: Literature review and caregiver survey.
    JoJo Yang QZ; Porter BE; Axeen ET
    Epilepsy Behav Rep; 2023; 21():100582. PubMed ID: 36654732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA Interference Effectors Selectively Silence the Pathogenic Variant
    Klementieva NV; Lunev EA; Shmidt AA; Loseva EM; Savchenko IM; Svetlova EA; Galkin II; Polikarpova AV; Usachev EV; Vassilieva SG; Marina VI; Dzhenkova MA; Romanova AD; Agutin AV; Timakova AA; Reshetov DA; Egorova TV; Bardina MV
    Nucleic Acid Ther; 2024 Apr; 34(2):90-99. PubMed ID: 38215303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DBS emergency surgery for treatment of dystonic storm associated with rhabdomyolysis and acute colitis in DYT-GNAO1.
    Chaib H; Schoene-Bake JC; Saryyeva A; Jack T; Hartmann H; Krauss JK
    Childs Nerv Syst; 2022 Sep; 38(9):1821-1824. PubMed ID: 35725943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.